Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Due to the current COVID situation, more whole birds are available to consumers and knowing that you have options is important when making food decisions when making grocery purchases. Most […]

AFTER THE FRACTURE If you have recently broken a bone, you have come to the right place! The information that follows will help you to understand the pain that you […]

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]

SCIENTIFIC ADVISORY COUNCIL We look to the best experts to inform our care guidelines for patients and care providers. Our Scientific Advisory Council (SAC) is made up of experts in […]

SAC Members and Research Our Members Our Scientific Advisory Council members are involved with many research projects.  Read ahead to learn more about our members and their research. Ahmed Negm […]

PRESS RELEASE TORONTO, November 19, 2020 – Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention. Dr. Famida Jiwa, President & CEO, Osteoporosis […]

Programs Osteoporosis and You Learn about the disease and gain a better understanding of how you or a loved one can live well with osteoporosis. Topics include nutrition, safe exercise, […]